Literature DB >> 11944990

Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.

Hong Chen1, Rey-Chen Pong, Zhi Wang, Jer-Tsong Hsieh.   

Abstract

Human DAB2IP (for DAB2 interaction protein) is a novel member of the RasGTPase-activating protein family. It interacts directly with DAB2, which suppresses growth of many cancer types. We demonstrated that DAB2IP is often downregulated in human prostate cancer cell lines. The predicted DAB2IP protein (967 amino acids) shares 94.2% homology with the rat DIP1/2 protein. We mapped the promoter of DAB2IP and studied its regulation in normal and malignant prostate cancer cells. This gene is located at 9q33.1-q33.3 and spans approximately 96 kb with 15 exons and 14 introns. The DAB2IP promoter does not contain any typical TATA box-evidenced by the presence of various RNAs with differential transcription starting sites. We further demonstrated that normal prostatic epithelial cells have elevated DAB2IP mRNA compared with cancer cells, which correlates with increased DAB2IP promoter activity. These data indicate that transcriptional regulation of DAB2IP is responsible for the downregulation of DAB2IP expression in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944990     DOI: 10.1006/geno.2002.6739

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  38 in total

1.  Dab2IP Regulates Neuronal Positioning, Rap1 Activity and Integrin Signaling in the Developing Cortex.

Authors:  Shuhong Qiao; Ramin Homayouni
Journal:  Dev Neurosci       Date:  2015-02-25       Impact factor: 2.984

Review 2.  Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.

Authors:  Kathryn E Ware; Mariano A Garcia-Blanco; Andrew J Armstrong; Scott M Dehm
Journal:  Endocr Relat Cancer       Date:  2014-05-23       Impact factor: 5.678

3.  Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.

Authors:  Solveig Gretarsdottir; Annette F Baas; Gudmar Thorleifsson; Hilma Holm; Martin den Heijer; Jean-Paul P M de Vries; Steef E Kranendonk; Clark J A M Zeebregts; Steven M van Sterkenburg; Robert H Geelkerken; Andre M van Rij; Michael J A Williams; Albert P M Boll; Jelena P Kostic; Adalbjorg Jonasdottir; Aslaug Jonasdottir; G Bragi Walters; Gisli Masson; Patrick Sulem; Jona Saemundsdottir; Magali Mouy; Kristinn P Magnusson; Gerard Tromp; James R Elmore; Natzi Sakalihasan; Raymond Limet; Jean-Olivier Defraigne; Robert E Ferrell; Antti Ronkainen; Ynte M Ruigrok; Cisca Wijmenga; Diederick E Grobbee; Svati H Shah; Christopher B Granger; Arshed A Quyyumi; Viola Vaccarino; Riyaz S Patel; A Maziar Zafari; Allan I Levey; Harland Austin; Domenico Girelli; Pier Franco Pignatti; Oliviero Olivieri; Nicola Martinelli; Giovanni Malerba; Elisabetta Trabetti; Lewis C Becker; Diane M Becker; Muredach P Reilly; Daniel J Rader; Thomas Mueller; Benjamin Dieplinger; Meinhard Haltmayer; Sigitas Urbonavicius; Bengt Lindblad; Anders Gottsäter; Eleonora Gaetani; Roberto Pola; Philip Wells; Marc Rodger; Melissa Forgie; Nicole Langlois; Javier Corral; Vicente Vicente; Jordi Fontcuberta; Francisco España; Niels Grarup; Torben Jørgensen; Daniel R Witte; Torben Hansen; Oluf Pedersen; Katja K Aben; Jacqueline de Graaf; Suzanne Holewijn; Lasse Folkersen; Anders Franco-Cereceda; Per Eriksson; David A Collier; Hreinn Stefansson; Valgerdur Steinthorsdottir; Thorunn Rafnar; Einar M Valdimarsson; Hulda B Magnadottir; Sigurlaug Sveinbjornsdottir; Isleifur Olafsson; Magnus Karl Magnusson; Robert Palmason; Vilhelmina Haraldsdottir; Karl Andersen; Pall T Onundarson; Gudmundur Thorgeirsson; Lambertus A Kiemeney; Janet T Powell; David J Carey; Helena Kuivaniemi; Jes S Lindholt; Gregory T Jones; Augustine Kong; Jan D Blankensteijn; Stefan E Matthiasson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

4.  Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.

Authors:  J Zhou; J Luo; K Wu; E-J Yun; P Kapur; R-C Pong; Y Du; B Wang; C Authement; E Hernandez; J Yang; G Xiao; T-L Cha; H-C Wu; D Wu; V Margulis; Y Lotan; J Brugarolas; D He; J-T Hsieh
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 5.  AIP1-mediated stress signaling in atherosclerosis and arteriosclerosis.

Authors:  Jiqin Zhang; Huanjiao Jenny Zhou; Weidong Ji; Wang Min
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

6.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

Review 7.  Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.

Authors:  Philip D King; Beth A Lubeck; Philip E Lapinski
Journal:  Sci Signal       Date:  2013-02-26       Impact factor: 8.192

8.  A Novel Monoclonal Antibody Against Human DAB2IP.

Authors:  He Xu; Dapeng Wei; Jianxin Xue; Lijuan Hu
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-08

9.  CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy.

Authors:  Liya Ding; Shuai Chen; Ping Liu; Yunqian Pan; Jian Zhong; Kevin M Regan; Liguo Wang; Chunrong Yu; Anthony Rizzardi; Liang Cheng; Jun Zhang; Stephen C Schmechel; John C Cheville; Jan Van Deursen; Donald J Tindall; Haojie Huang
Journal:  Cancer Res       Date:  2014-02-03       Impact factor: 12.701

10.  AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3.

Authors:  Rong Zhang; Xiangrong He; Weimin Liu; Meng Lu; Jer-Tsong Hsieh; Wang Min
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.